Manufacturer copay assistance · Opdualag (J9298) · Bristol Myers Squibb
Patient pays first $25… · Maximum benefit Up to $25,000 per calendar year, per BMS medication · Covers drug cost only — administration billed separately
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
Run a benefits estimate for Opdualag — the program's cap applies against the patient share CareCost calculates.
Yes — BMS Access Support Oncology Co-Pay Assistance (Opdualag) from Bristol Myers Squibb. Patient pays first $25 of co-pay per dose. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Patient pays first $25 of co-pay per dose Maximum benefit: Up to $25,000 per calendar year, per BMS medication. Covers drug cost only — administration billed separately
Accepted insurance: commercial. Not eligible: medicaid, medicare, government.